Cefuroxime acetil, amorphous

Available EU dossier in development

Offer available for: licensing

Pharmaceutical form and dosage: 125-250 mg / 5 ml oral suspension

Type:

- Generics
- Pharmaceuticals / Therapeutics
- Prescription drugs (Rx)

Therapeutic target:

- Infectious Diseases

Action: Antibiotics - systemic (anti-infectives)

Full Description:
Cefuroxime acetil amorphous 125-250 mg / 5 ml oral suspension dossier is is a EU-dossier in development and available soon for licensing.

Note that Cefuroxime acetil crystalline 250-500 mg tablets dossier is a new readily available dossier for licensing

Availability and Market information:

Status: Development

Market information

Other Market Info:

Patent Information:
Name: Zinnat
Patent expiration date: 2003
Patent info: Development of pharmaceuticals which are still under patent is carried out according to EU-requirements in countries with no existing patents or with Bolar-provisions.
We deliver to all countries where the substance and its use are not protected by patents.